Fornaro Gianluigi, Lazzero Maurizio, Giacalone Angela, Aralda Donatella, Prando Maria Domenica, Rossi Lidia, Bongo Angelo Sante
Unità Coronarica, II Divisione di Cardiologia, A.O. Maggiore della Carità, Novara.
G Ital Cardiol (Rome). 2008 Jun;9(6):408-20.
Experimental clinical observations suggest that fibrinolysis (FL) in acute myocardial infarction, even though reducing global mortality, is associated with an increasing incidence of death in the first 24-48 h. The responsible mechanism is not yet known, although available evidence supports heart rupture as the possible cause.
We studied 154 patients at autopsy who died of cardiac causes from January 1, 1994 to December 31, 2005 among a cohort of 2260 patients who were admitted for ST-elevation myocardial infarction. They were divided into three therapeutic groups-- FL, coronary angioplasty (PTCA) and conventional therapy (CT)--in order to assess the incidence of cardiac rupture and compare it with the other causes of cardiac death.
Of the 896 patients (39.7%) who were treated with FL, 57 (6.4%) died; of the 804 (35.6%) treated with PTCA, 40 (5.05%) died, and of the 560 (24.7%) treated with CT, 57 (10.2%) died (p < 0.05 in the two first groups vs CT). We studied at autopsy 154 patients (mortality 6.7%). The mean admission delay was 5.05 h in the FL group, 7.04 h in the PTCA group, and 7.05 h in the CT group. Cardiac death occurred on average after 13 h in the FL group, after 15 h in the PTCA group, and after 19 h in the CT group. The cause of death was due to cardiac rupture in 56 patients (36.5%), to shock in 55 patients (35.7%), to electromechanical dissociation in 29 patients (18.8%), and to cardiac failure in 14 patients (9%). In the FL and PTCA groups, cardiac rupture was the major, and also the earliest (10 e 12 h, respectively), cause of death, whereas in the CT group cardiac shock (13 h) was the major cause of death. Anterior myocardial infarction (n = 104, 65%) was more prevalent in deceased patients, whereas inferior myocardial infarction was found in the other 50 cases (35%). Cardiac rupture was more prevalent in anterior myocardial infarction. In the FL and PTCA groups, histological examination showed unusual hemorrhagic infiltration in the necrotic areas with presence of leukocytes.
Our study shows that cardiac rupture is the major cause of death in patients with ST-elevation myocardial infarction treated with FL and PTCA, suggesting that mechanical and lythic reperfusion injury, in coagulative necrosis, may represent a further cause of cardiac rupture that occurs early or within the first hours.
实验性临床观察表明,急性心肌梗死中的纤维蛋白溶解(FL),尽管能降低总体死亡率,但与最初24 - 48小时内死亡发生率的增加有关。尽管现有证据支持心脏破裂是可能的原因,但具体机制尚不清楚。
我们研究了1994年1月1日至2005年12月31日期间因ST段抬高型心肌梗死入院的2260例患者队列中,154例死于心脏原因的尸检患者。他们被分为三个治疗组——纤维蛋白溶解组(FL)、冠状动脉血管成形术(PTCA)组和传统治疗组(CT),以评估心脏破裂的发生率,并与其他心脏死亡原因进行比较。
在接受FL治疗的896例患者(39.7%)中,57例(6.4%)死亡;在接受PTCA治疗得804例(35.6%)患者中,40例(5.05%)死亡;在接受CT治疗的560例(24.7%)患者中,57例(10.2%)死亡(前两组与CT组相比,p < 0.05)。我们对154例患者进行了尸检研究(死亡率6.7%)。FL组的平均入院延迟为5.05小时,PTCA组为7.04小时,CT组为7.05小时。FL组心脏死亡平均发生在13小时后;PTCA组在15小时后;CT组在19小时后。死亡原因中,56例(36.5%)是心脏破裂,55例(35.7%)是休克,29例(18.8%)是电机械分离,14例(9%)是心力衰竭。在FL组和PTCA组中,心脏破裂是主要且也是最早(分别为10至12小时)的死亡原因,而在CT组中,心源性休克(13小时)是主要死亡原因。前壁心肌梗死(n = 104,65%)在死亡患者中更为常见,而其他50例(35%)为下壁心肌梗死。心脏破裂在前壁心肌梗死中更为常见。在FL组和PTCA组中,组织学检查显示坏死区域有异常的出血性浸润并伴有白细胞。
我们的研究表明,心脏破裂是接受FL和PTCA治疗的ST段抬高型心肌梗死患者的主要死亡原因,提示在凝固性坏死中,机械性和溶栓性再灌注损伤可能是早期或最初几小时内发生心脏破裂的另一个原因。